nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenelzine—CYP3A43—Dexamethasone—multiple sclerosis	0.202	0.291	CbGbCtD
Phenelzine—CYP2E1—Fingolimod—multiple sclerosis	0.116	0.168	CbGbCtD
Phenelzine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0547	0.079	CbGbCtD
Phenelzine—CYP3A4—Fingolimod—multiple sclerosis	0.0353	0.0509	CbGbCtD
Phenelzine—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0294	0.0424	CbGbCtD
Phenelzine—CYP3A7—Dexamethasone—multiple sclerosis	0.0294	0.0424	CbGbCtD
Phenelzine—CYP2C19—Prednisone—multiple sclerosis	0.0285	0.0411	CbGbCtD
Phenelzine—CYP2E1—Dexamethasone—multiple sclerosis	0.0284	0.0409	CbGbCtD
Phenelzine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0227	0.0328	CbGbCtD
Phenelzine—CYP3A5—Dexamethasone—multiple sclerosis	0.022	0.0318	CbGbCtD
Phenelzine—CYP2C8—Dexamethasone—multiple sclerosis	0.0212	0.0306	CbGbCtD
Phenelzine—CYP2C19—Dexamethasone—multiple sclerosis	0.0178	0.0257	CbGbCtD
Phenelzine—CYP3A4—Triamcinolone—multiple sclerosis	0.0172	0.0249	CbGbCtD
Phenelzine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0166	0.0239	CbGbCtD
Phenelzine—CYP3A4—Betamethasone—multiple sclerosis	0.0148	0.0213	CbGbCtD
Phenelzine—CYP3A4—Prednisolone—multiple sclerosis	0.0146	0.021	CbGbCtD
Phenelzine—CYP3A4—Prednisone—multiple sclerosis	0.0138	0.0199	CbGbCtD
Phenelzine—AOC3—peripheral nervous system—multiple sclerosis	0.0101	0.113	CbGeAlD
Phenelzine—CYP3A4—Dexamethasone—multiple sclerosis	0.0086	0.0124	CbGbCtD
Phenelzine—AOC3—retina—multiple sclerosis	0.00325	0.0364	CbGeAlD
Phenelzine—MAOB—nerve—multiple sclerosis	0.00323	0.0361	CbGeAlD
Phenelzine—ABAT—brainstem—multiple sclerosis	0.00285	0.0318	CbGeAlD
Phenelzine—MAOA—nerve—multiple sclerosis	0.00276	0.0308	CbGeAlD
Phenelzine—ABAT—retina—multiple sclerosis	0.00275	0.0307	CbGeAlD
Phenelzine—GPT2—medulla oblongata—multiple sclerosis	0.00271	0.0303	CbGeAlD
Phenelzine—GPT—nervous system—multiple sclerosis	0.00266	0.0297	CbGeAlD
Phenelzine—GPT2—Amino acid and derivative metabolism—SRM—multiple sclerosis	0.00266	0.0427	CbGpPWpGaD
Phenelzine—GPT—central nervous system—multiple sclerosis	0.00256	0.0286	CbGeAlD
Phenelzine—GPT—cerebellum—multiple sclerosis	0.0025	0.028	CbGeAlD
Phenelzine—GPT2—midbrain—multiple sclerosis	0.00247	0.0277	CbGeAlD
Phenelzine—GPT2—spinal cord—multiple sclerosis	0.00241	0.027	CbGeAlD
Phenelzine—AOC3—medulla oblongata—multiple sclerosis	0.00235	0.0263	CbGeAlD
Phenelzine—GPT—Amino acid and derivative metabolism—SRM—multiple sclerosis	0.00217	0.0348	CbGpPWpGaD
Phenelzine—AOC3—midbrain—multiple sclerosis	0.00215	0.024	CbGeAlD
Phenelzine—GPT2—nervous system—multiple sclerosis	0.00203	0.0227	CbGeAlD
Phenelzine—GPT—brain—multiple sclerosis	0.00203	0.0227	CbGeAlD
Phenelzine—ABAT—medulla oblongata—multiple sclerosis	0.00199	0.0222	CbGeAlD
Phenelzine—GPT2—central nervous system—multiple sclerosis	0.00196	0.0219	CbGeAlD
Phenelzine—GPT2—cerebellum—multiple sclerosis	0.00191	0.0214	CbGeAlD
Phenelzine—ABAT—midbrain—multiple sclerosis	0.00182	0.0203	CbGeAlD
Phenelzine—ABAT—spinal cord—multiple sclerosis	0.00177	0.0198	CbGeAlD
Phenelzine—AOC3—nervous system—multiple sclerosis	0.00177	0.0197	CbGeAlD
Phenelzine—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—multiple sclerosis	0.00172	0.0276	CbGpPWpGaD
Phenelzine—AOC3—central nervous system—multiple sclerosis	0.0017	0.019	CbGeAlD
Phenelzine—AOC3—cerebellum—multiple sclerosis	0.00166	0.0186	CbGeAlD
Phenelzine—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00166	0.0266	CbGpPWpGaD
Phenelzine—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00166	0.0266	CbGpPWpGaD
Phenelzine—CYP3A43—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00164	0.0262	CbGpPWpGaD
Phenelzine—CYP3A43—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00164	0.0262	CbGpPWpGaD
Phenelzine—GPT2—brain—multiple sclerosis	0.00155	0.0174	CbGeAlD
Phenelzine—ABAT—nervous system—multiple sclerosis	0.00149	0.0167	CbGeAlD
Phenelzine—ABAT—central nervous system—multiple sclerosis	0.00144	0.0161	CbGeAlD
Phenelzine—ABAT—cerebellum—multiple sclerosis	0.0014	0.0157	CbGeAlD
Phenelzine—MAOB—brainstem—multiple sclerosis	0.00139	0.0155	CbGeAlD
Phenelzine—AOC3—brain—multiple sclerosis	0.00135	0.0151	CbGeAlD
Phenelzine—CYP3A43—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00134	0.0216	CbGpPWpGaD
Phenelzine—CYP3A43—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00134	0.0216	CbGpPWpGaD
Phenelzine—MAOA—brainstem—multiple sclerosis	0.00118	0.0132	CbGeAlD
Phenelzine—MAOA—retina—multiple sclerosis	0.00114	0.0128	CbGeAlD
Phenelzine—ABAT—brain—multiple sclerosis	0.00114	0.0128	CbGeAlD
Phenelzine—ABAT—Neuronal System—KCNA3—multiple sclerosis	0.00111	0.0179	CbGpPWpGaD
Phenelzine—MAOB—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00102	0.0163	CbGpPWpGaD
Phenelzine—MAOB—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00102	0.0163	CbGpPWpGaD
Phenelzine—MAOB—medulla oblongata—multiple sclerosis	0.000967	0.0108	CbGeAlD
Phenelzine—MAOB—midbrain—multiple sclerosis	0.000884	0.00988	CbGeAlD
Phenelzine—MAOB—spinal cord—multiple sclerosis	0.000862	0.00964	CbGeAlD
Phenelzine—Delirium—Prednisone—multiple sclerosis	0.000837	0.00539	CcSEcCtD
Phenelzine—Asthenia—Fingolimod—multiple sclerosis	0.00083	0.00534	CcSEcCtD
Phenelzine—MAOA—medulla oblongata—multiple sclerosis	0.000825	0.00922	CbGeAlD
Phenelzine—Pruritus—Fingolimod—multiple sclerosis	0.000818	0.00527	CcSEcCtD
Phenelzine—Euphoric mood—Triamcinolone—multiple sclerosis	0.000783	0.00504	CcSEcCtD
Phenelzine—Euphoric mood—Methylprednisolone—multiple sclerosis	0.000781	0.00503	CcSEcCtD
Phenelzine—Dizziness—Fingolimod—multiple sclerosis	0.000765	0.00492	CcSEcCtD
Phenelzine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000762	0.0122	CbGpPWpGaD
Phenelzine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000762	0.0122	CbGpPWpGaD
Phenelzine—MAOA—midbrain—multiple sclerosis	0.000754	0.00843	CbGeAlD
Phenelzine—MAOA—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000752	0.0121	CbGpPWpGaD
Phenelzine—Ill-defined disorder—Cladribine—multiple sclerosis	0.000745	0.0048	CcSEcCtD
Phenelzine—MAOA—spinal cord—multiple sclerosis	0.000736	0.00822	CbGeAlD
Phenelzine—MAOB—nervous system—multiple sclerosis	0.000726	0.00812	CbGeAlD
Phenelzine—Headache—Fingolimod—multiple sclerosis	0.000724	0.00466	CcSEcCtD
Phenelzine—Malaise—Cladribine—multiple sclerosis	0.000724	0.00466	CcSEcCtD
Phenelzine—CYP3A43—Biological oxidations—CYP27B1—multiple sclerosis	0.000714	0.0115	CbGpPWpGaD
Phenelzine—CYP3A43—Biological oxidations—CYP24A1—multiple sclerosis	0.000714	0.0115	CbGpPWpGaD
Phenelzine—Euphoric mood—Dexamethasone—multiple sclerosis	0.00071	0.00457	CcSEcCtD
Phenelzine—Euphoric mood—Betamethasone—multiple sclerosis	0.00071	0.00457	CcSEcCtD
Phenelzine—CYP3A43—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000704	0.0113	CbGpPWpGaD
Phenelzine—CYP3A43—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000704	0.0113	CbGpPWpGaD
Phenelzine—MAOB—central nervous system—multiple sclerosis	0.000699	0.00782	CbGeAlD
Phenelzine—Erectile dysfunction—Mitoxantrone—multiple sclerosis	0.000698	0.00449	CcSEcCtD
Phenelzine—Weight increased—Mitoxantrone—multiple sclerosis	0.000689	0.00444	CcSEcCtD
Phenelzine—MAOB—cerebellum—multiple sclerosis	0.000684	0.00764	CbGeAlD
Phenelzine—Anxiety—Cladribine—multiple sclerosis	0.000681	0.00439	CcSEcCtD
Phenelzine—Discomfort—Cladribine—multiple sclerosis	0.000676	0.00435	CcSEcCtD
Phenelzine—Drowsiness—Mitoxantrone—multiple sclerosis	0.000675	0.00435	CcSEcCtD
Phenelzine—CYP3A5—Irinotecan Pathway—BCHE—multiple sclerosis	0.000673	0.0108	CbGpPWpGaD
Phenelzine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000668	0.0107	CbGpPWpGaD
Phenelzine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000668	0.0107	CbGpPWpGaD
Phenelzine—CYP3A7—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000659	0.0106	CbGpPWpGaD
Phenelzine—CYP3A7—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000659	0.0106	CbGpPWpGaD
Phenelzine—Jaundice—Mitoxantrone—multiple sclerosis	0.000658	0.00424	CcSEcCtD
Phenelzine—Oedema—Cladribine—multiple sclerosis	0.000655	0.00422	CcSEcCtD
Phenelzine—Sweating—Mitoxantrone—multiple sclerosis	0.000648	0.00417	CcSEcCtD
Phenelzine—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.000644	0.00415	CcSEcCtD
Phenelzine—Tachycardia—Cladribine—multiple sclerosis	0.00064	0.00412	CcSEcCtD
Phenelzine—MAOA—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000639	0.0103	CbGpPWpGaD
Phenelzine—MAOA—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000639	0.0103	CbGpPWpGaD
Phenelzine—Hyperhidrosis—Cladribine—multiple sclerosis	0.000634	0.00408	CcSEcCtD
Phenelzine—MAOA—nervous system—multiple sclerosis	0.00062	0.00693	CbGeAlD
Phenelzine—CYP2E1—medulla oblongata—multiple sclerosis	0.000619	0.00692	CbGeAlD
Phenelzine—Euphoric mood—Prednisone—multiple sclerosis	0.000619	0.00398	CcSEcCtD
Phenelzine—Ill-defined disorder—Azathioprine—multiple sclerosis	0.000606	0.0039	CcSEcCtD
Phenelzine—MAOA—central nervous system—multiple sclerosis	0.000597	0.00667	CbGeAlD
Phenelzine—Insomnia—Cladribine—multiple sclerosis	0.000593	0.00382	CcSEcCtD
Phenelzine—Malaise—Azathioprine—multiple sclerosis	0.000589	0.00379	CcSEcCtD
Phenelzine—Paraesthesia—Cladribine—multiple sclerosis	0.000589	0.00379	CcSEcCtD
Phenelzine—Psychotic disorder—Betamethasone—multiple sclerosis	0.000586	0.00377	CcSEcCtD
Phenelzine—Psychotic disorder—Dexamethasone—multiple sclerosis	0.000586	0.00377	CcSEcCtD
Phenelzine—Leukopenia—Azathioprine—multiple sclerosis	0.000585	0.00376	CcSEcCtD
Phenelzine—MAOA—cerebellum—multiple sclerosis	0.000583	0.00652	CbGeAlD
Phenelzine—Somnolence—Cladribine—multiple sclerosis	0.000583	0.00375	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000566	0.00364	CcSEcCtD
Phenelzine—Weight increased—Prednisolone—multiple sclerosis	0.000566	0.00364	CcSEcCtD
Phenelzine—Fatigue—Cladribine—multiple sclerosis	0.000565	0.00364	CcSEcCtD
Phenelzine—Constipation—Cladribine—multiple sclerosis	0.00056	0.00361	CcSEcCtD
Phenelzine—MAOB—brain—multiple sclerosis	0.000555	0.00621	CbGeAlD
Phenelzine—CYP2E1—spinal cord—multiple sclerosis	0.000552	0.00617	CbGeAlD
Phenelzine—Coma—Methotrexate—multiple sclerosis	0.00055	0.00354	CcSEcCtD
Phenelzine—Discomfort—Azathioprine—multiple sclerosis	0.000549	0.00354	CcSEcCtD
Phenelzine—CYP3A7—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000541	0.00868	CbGpPWpGaD
Phenelzine—CYP3A7—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000541	0.00868	CbGpPWpGaD
Phenelzine—MAOB—Biological oxidations—CYP27B1—multiple sclerosis	0.000541	0.00868	CbGpPWpGaD
Phenelzine—MAOB—Biological oxidations—CYP24A1—multiple sclerosis	0.000541	0.00868	CbGpPWpGaD
Phenelzine—Feeling abnormal—Cladribine—multiple sclerosis	0.00054	0.00348	CcSEcCtD
Phenelzine—Weight increased—Triamcinolone—multiple sclerosis	0.00052	0.00335	CcSEcCtD
Phenelzine—Weight increased—Methylprednisolone—multiple sclerosis	0.000519	0.00334	CcSEcCtD
Phenelzine—Body temperature increased—Cladribine—multiple sclerosis	0.000518	0.00333	CcSEcCtD
Phenelzine—MAOA—Serotonin Transporter Activity—IL1B—multiple sclerosis	0.000511	0.0082	CbGpPWpGaD
Phenelzine—Psychotic disorder—Prednisone—multiple sclerosis	0.00051	0.00328	CcSEcCtD
Phenelzine—Vision blurred—Mitoxantrone—multiple sclerosis	0.000497	0.0032	CcSEcCtD
Phenelzine—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.00049	0.00315	CcSEcCtD
Phenelzine—GPT2—Metabolism—SRM—multiple sclerosis	0.000488	0.00783	CbGpPWpGaD
Phenelzine—Sweating—Methylprednisolone—multiple sclerosis	0.000487	0.00314	CcSEcCtD
Phenelzine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000484	0.00776	CbGpPWpGaD
Phenelzine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000484	0.00776	CbGpPWpGaD
Phenelzine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000483	0.00774	CbGpPWpGaD
Phenelzine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000483	0.00774	CbGpPWpGaD
Phenelzine—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000477	0.00766	CbGpPWpGaD
Phenelzine—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000477	0.00766	CbGpPWpGaD
Phenelzine—CYP3A5—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000476	0.00764	CbGpPWpGaD
Phenelzine—CYP3A5—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000476	0.00764	CbGpPWpGaD
Phenelzine—Malaise—Mitoxantrone—multiple sclerosis	0.000476	0.00306	CcSEcCtD
Phenelzine—MAOA—brain—multiple sclerosis	0.000474	0.0053	CbGeAlD
Phenelzine—Leukopenia—Mitoxantrone—multiple sclerosis	0.000473	0.00304	CcSEcCtD
Phenelzine—Weight increased—Dexamethasone—multiple sclerosis	0.000472	0.00304	CcSEcCtD
Phenelzine—Weight increased—Betamethasone—multiple sclerosis	0.000472	0.00304	CcSEcCtD
Phenelzine—Asthenia—Cladribine—multiple sclerosis	0.00047	0.00303	CcSEcCtD
Phenelzine—CYP2E1—nervous system—multiple sclerosis	0.000465	0.0052	CbGeAlD
Phenelzine—Pruritus—Cladribine—multiple sclerosis	0.000464	0.00298	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00046	0.00296	CcSEcCtD
Phenelzine—Convulsion—Mitoxantrone—multiple sclerosis	0.000457	0.00294	CcSEcCtD
Phenelzine—CYP2E1—central nervous system—multiple sclerosis	0.000448	0.00501	CbGeAlD
Phenelzine—Anxiety—Mitoxantrone—multiple sclerosis	0.000448	0.00288	CcSEcCtD
Phenelzine—Discomfort—Mitoxantrone—multiple sclerosis	0.000444	0.00286	CcSEcCtD
Phenelzine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000439	0.00283	CcSEcCtD
Phenelzine—CYP2E1—cerebellum—multiple sclerosis	0.000438	0.00489	CbGeAlD
Phenelzine—Dizziness—Cladribine—multiple sclerosis	0.000433	0.00279	CcSEcCtD
Phenelzine—Oedema—Mitoxantrone—multiple sclerosis	0.000431	0.00277	CcSEcCtD
Phenelzine—Shock—Mitoxantrone—multiple sclerosis	0.000424	0.00273	CcSEcCtD
Phenelzine—CYP2C8—brain—multiple sclerosis	0.000422	0.00472	CbGeAlD
Phenelzine—Body temperature increased—Azathioprine—multiple sclerosis	0.000421	0.00271	CcSEcCtD
Phenelzine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00042	0.00271	CcSEcCtD
Phenelzine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000418	0.00671	CbGpPWpGaD
Phenelzine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000418	0.00671	CbGpPWpGaD
Phenelzine—Vomiting—Cladribine—multiple sclerosis	0.000417	0.00268	CcSEcCtD
Phenelzine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000416	0.00268	CcSEcCtD
Phenelzine—Erectile dysfunction—Prednisone—multiple sclerosis	0.000416	0.00268	CcSEcCtD
Phenelzine—Rash—Cladribine—multiple sclerosis	0.000413	0.00266	CcSEcCtD
Phenelzine—Dermatitis—Cladribine—multiple sclerosis	0.000413	0.00266	CcSEcCtD
Phenelzine—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000413	0.00662	CbGpPWpGaD
Phenelzine—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000413	0.00662	CbGpPWpGaD
Phenelzine—Weight increased—Prednisone—multiple sclerosis	0.000411	0.00265	CcSEcCtD
Phenelzine—Ataxia—Methotrexate—multiple sclerosis	0.000411	0.00264	CcSEcCtD
Phenelzine—Headache—Cladribine—multiple sclerosis	0.000411	0.00264	CcSEcCtD
Phenelzine—Vision blurred—Prednisolone—multiple sclerosis	0.000408	0.00263	CcSEcCtD
Phenelzine—ABAT—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000408	0.00654	CbGpPWpGaD
Phenelzine—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000402	0.00259	CcSEcCtD
Phenelzine—GPT—Metabolism—SRM—multiple sclerosis	0.000398	0.00639	CbGpPWpGaD
Phenelzine—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000392	0.00629	CbGpPWpGaD
Phenelzine—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000392	0.00629	CbGpPWpGaD
Phenelzine—CYP3A5—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000391	0.00628	CbGpPWpGaD
Phenelzine—CYP3A5—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000391	0.00628	CbGpPWpGaD
Phenelzine—Malaise—Prednisolone—multiple sclerosis	0.000391	0.00251	CcSEcCtD
Phenelzine—Nausea—Cladribine—multiple sclerosis	0.000389	0.00251	CcSEcCtD
Phenelzine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000387	0.00249	CcSEcCtD
Phenelzine—Somnolence—Mitoxantrone—multiple sclerosis	0.000383	0.00247	CcSEcCtD
Phenelzine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000379	0.00244	CcSEcCtD
Phenelzine—Convulsion—Prednisolone—multiple sclerosis	0.000375	0.00242	CcSEcCtD
Phenelzine—CYP3A4—nervous system—multiple sclerosis	0.000374	0.00418	CbGeAlD
Phenelzine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000373	0.00599	CbGpPWpGaD
Phenelzine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000373	0.00599	CbGpPWpGaD
Phenelzine—CYP3A43—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000373	0.00598	CbGpPWpGaD
Phenelzine—Fatigue—Mitoxantrone—multiple sclerosis	0.000371	0.00239	CcSEcCtD
Phenelzine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00037	0.00238	CcSEcCtD
Phenelzine—MAOA—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000369	0.00592	CbGpPWpGaD
Phenelzine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000369	0.00237	CcSEcCtD
Phenelzine—Constipation—Mitoxantrone—multiple sclerosis	0.000368	0.00237	CcSEcCtD
Phenelzine—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000368	0.00591	CbGpPWpGaD
Phenelzine—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000368	0.00591	CbGpPWpGaD
Phenelzine—Discomfort—Prednisolone—multiple sclerosis	0.000364	0.00234	CcSEcCtD
Phenelzine—CYP3A4—central nervous system—multiple sclerosis	0.00036	0.00403	CbGeAlD
Phenelzine—Malaise—Triamcinolone—multiple sclerosis	0.000359	0.00231	CcSEcCtD
Phenelzine—Malaise—Methylprednisolone—multiple sclerosis	0.000358	0.00231	CcSEcCtD
Phenelzine—MAOA—Neuronal System—KCNA3—multiple sclerosis	0.000358	0.00574	CbGpPWpGaD
Phenelzine—CYP2E1—brain—multiple sclerosis	0.000356	0.00398	CbGeAlD
Phenelzine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000355	0.00228	CcSEcCtD
Phenelzine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000353	0.00567	CbGpPWpGaD
Phenelzine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000353	0.00567	CbGpPWpGaD
Phenelzine—Oedema—Prednisolone—multiple sclerosis	0.000353	0.00227	CcSEcCtD
Phenelzine—Dizziness—Azathioprine—multiple sclerosis	0.000352	0.00227	CcSEcCtD
Phenelzine—Shock—Prednisolone—multiple sclerosis	0.000348	0.00224	CcSEcCtD
Phenelzine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000348	0.00224	CcSEcCtD
Phenelzine—Convulsion—Triamcinolone—multiple sclerosis	0.000345	0.00222	CcSEcCtD
Phenelzine—Tachycardia—Prednisolone—multiple sclerosis	0.000345	0.00222	CcSEcCtD
Phenelzine—Convulsion—Methylprednisolone—multiple sclerosis	0.000344	0.00222	CcSEcCtD
Phenelzine—GPT2—Metabolism—CYP27B1—multiple sclerosis	0.000344	0.00552	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—CYP24A1—multiple sclerosis	0.000344	0.00552	CbGpPWpGaD
Phenelzine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000342	0.0022	CcSEcCtD
Phenelzine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000341	0.00219	CcSEcCtD
Phenelzine—MAOA—Biological oxidations—CYP27B1—multiple sclerosis	0.000339	0.00545	CbGpPWpGaD
Phenelzine—MAOA—Biological oxidations—CYP24A1—multiple sclerosis	0.000339	0.00545	CbGpPWpGaD
Phenelzine—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000339	0.00544	CbGpPWpGaD
Phenelzine—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000339	0.00544	CbGpPWpGaD
Phenelzine—Vomiting—Azathioprine—multiple sclerosis	0.000339	0.00218	CcSEcCtD
Phenelzine—Anxiety—Methylprednisolone—multiple sclerosis	0.000337	0.00217	CcSEcCtD
Phenelzine—Drowsiness—Methotrexate—multiple sclerosis	0.000337	0.00217	CcSEcCtD
Phenelzine—Rash—Azathioprine—multiple sclerosis	0.000336	0.00216	CcSEcCtD
Phenelzine—Dermatitis—Azathioprine—multiple sclerosis	0.000336	0.00216	CcSEcCtD
Phenelzine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000335	0.00216	CcSEcCtD
Phenelzine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000335	0.00216	CcSEcCtD
Phenelzine—Discomfort—Triamcinolone—multiple sclerosis	0.000335	0.00216	CcSEcCtD
Phenelzine—Discomfort—Methylprednisolone—multiple sclerosis	0.000334	0.00215	CcSEcCtD
Phenelzine—Headache—Azathioprine—multiple sclerosis	0.000334	0.00215	CcSEcCtD
Phenelzine—Dry mouth—Triamcinolone—multiple sclerosis	0.000332	0.00213	CcSEcCtD
Phenelzine—Malaise—Dexamethasone—multiple sclerosis	0.000326	0.0021	CcSEcCtD
Phenelzine—Malaise—Betamethasone—multiple sclerosis	0.000326	0.0021	CcSEcCtD
Phenelzine—Oedema—Triamcinolone—multiple sclerosis	0.000325	0.00209	CcSEcCtD
Phenelzine—Sweating—Methotrexate—multiple sclerosis	0.000323	0.00208	CcSEcCtD
Phenelzine—Shock—Triamcinolone—multiple sclerosis	0.00032	0.00206	CcSEcCtD
Phenelzine—Insomnia—Prednisolone—multiple sclerosis	0.00032	0.00206	CcSEcCtD
Phenelzine—Shock—Methylprednisolone—multiple sclerosis	0.000319	0.00205	CcSEcCtD
Phenelzine—Paraesthesia—Prednisolone—multiple sclerosis	0.000317	0.00204	CcSEcCtD
Phenelzine—Tachycardia—Triamcinolone—multiple sclerosis	0.000317	0.00204	CcSEcCtD
Phenelzine—Nausea—Azathioprine—multiple sclerosis	0.000317	0.00204	CcSEcCtD
Phenelzine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000317	0.00204	CcSEcCtD
Phenelzine—GPT2—Metabolism—GPC5—multiple sclerosis	0.000315	0.00505	CbGpPWpGaD
Phenelzine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000314	0.00202	CcSEcCtD
Phenelzine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000314	0.00202	CcSEcCtD
Phenelzine—Convulsion—Dexamethasone—multiple sclerosis	0.000313	0.00202	CcSEcCtD
Phenelzine—Convulsion—Betamethasone—multiple sclerosis	0.000313	0.00202	CcSEcCtD
Phenelzine—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000313	0.00502	CbGpPWpGaD
Phenelzine—ABAT—Neuronal System—BCHE—multiple sclerosis	0.000312	0.00501	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000312	0.00501	CbGpPWpGaD
Phenelzine—Asthenia—Mitoxantrone—multiple sclerosis	0.000309	0.00199	CcSEcCtD
Phenelzine—Anxiety—Betamethasone—multiple sclerosis	0.000307	0.00197	CcSEcCtD
Phenelzine—Anxiety—Dexamethasone—multiple sclerosis	0.000307	0.00197	CcSEcCtD
Phenelzine—Discomfort—Dexamethasone—multiple sclerosis	0.000304	0.00196	CcSEcCtD
Phenelzine—Discomfort—Betamethasone—multiple sclerosis	0.000304	0.00196	CcSEcCtD
Phenelzine—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000302	0.00485	CbGpPWpGaD
Phenelzine—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000302	0.00485	CbGpPWpGaD
Phenelzine—CYP3A43—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000302	0.00485	CbGpPWpGaD
Phenelzine—Vision blurred—Prednisone—multiple sclerosis	0.000297	0.00191	CcSEcCtD
Phenelzine—Oedema—Dexamethasone—multiple sclerosis	0.000295	0.0019	CcSEcCtD
Phenelzine—Oedema—Betamethasone—multiple sclerosis	0.000295	0.0019	CcSEcCtD
Phenelzine—Insomnia—Triamcinolone—multiple sclerosis	0.000294	0.00189	CcSEcCtD
Phenelzine—Insomnia—Methylprednisolone—multiple sclerosis	0.000293	0.00189	CcSEcCtD
Phenelzine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000292	0.00188	CcSEcCtD
Phenelzine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000292	0.00188	CcSEcCtD
Phenelzine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000291	0.00187	CcSEcCtD
Phenelzine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000291	0.00187	CcSEcCtD
Phenelzine—Shock—Dexamethasone—multiple sclerosis	0.00029	0.00187	CcSEcCtD
Phenelzine—Shock—Betamethasone—multiple sclerosis	0.00029	0.00187	CcSEcCtD
Phenelzine—Agitation—Prednisone—multiple sclerosis	0.000289	0.00186	CcSEcCtD
Phenelzine—Tachycardia—Dexamethasone—multiple sclerosis	0.000288	0.00185	CcSEcCtD
Phenelzine—Tachycardia—Betamethasone—multiple sclerosis	0.000288	0.00185	CcSEcCtD
Phenelzine—CYP3A7—Biological oxidations—CYP24A1—multiple sclerosis	0.000288	0.00461	CbGpPWpGaD
Phenelzine—CYP3A7—Biological oxidations—CYP27B1—multiple sclerosis	0.000288	0.00461	CbGpPWpGaD
Phenelzine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000286	0.00184	CcSEcCtD
Phenelzine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000285	0.00184	CcSEcCtD
Phenelzine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000285	0.00184	CcSEcCtD
Phenelzine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000285	0.00184	CcSEcCtD
Phenelzine—Malaise—Prednisone—multiple sclerosis	0.000284	0.00183	CcSEcCtD
Phenelzine—CYP3A7—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000284	0.00455	CbGpPWpGaD
Phenelzine—CYP3A7—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000284	0.00455	CbGpPWpGaD
Phenelzine—GPT—Metabolism—CYP27B1—multiple sclerosis	0.00028	0.0045	CbGpPWpGaD
Phenelzine—GPT—Metabolism—CYP24A1—multiple sclerosis	0.00028	0.0045	CbGpPWpGaD
Phenelzine—Fatigue—Triamcinolone—multiple sclerosis	0.00028	0.0018	CcSEcCtD
Phenelzine—Fatigue—Methylprednisolone—multiple sclerosis	0.00028	0.0018	CcSEcCtD
Phenelzine—Vomiting—Mitoxantrone—multiple sclerosis	0.000274	0.00176	CcSEcCtD
Phenelzine—Convulsion—Prednisone—multiple sclerosis	0.000273	0.00175	CcSEcCtD
Phenelzine—Rash—Mitoxantrone—multiple sclerosis	0.000272	0.00175	CcSEcCtD
Phenelzine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000271	0.00175	CcSEcCtD
Phenelzine—Headache—Mitoxantrone—multiple sclerosis	0.00027	0.00174	CcSEcCtD
Phenelzine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000268	0.00172	CcSEcCtD
Phenelzine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000267	0.00172	CcSEcCtD
Phenelzine—Anxiety—Prednisone—multiple sclerosis	0.000267	0.00172	CcSEcCtD
Phenelzine—Insomnia—Betamethasone—multiple sclerosis	0.000267	0.00172	CcSEcCtD
Phenelzine—Insomnia—Dexamethasone—multiple sclerosis	0.000267	0.00172	CcSEcCtD
Phenelzine—Paraesthesia—Betamethasone—multiple sclerosis	0.000265	0.0017	CcSEcCtD
Phenelzine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000265	0.0017	CcSEcCtD
Phenelzine—Discomfort—Prednisone—multiple sclerosis	0.000265	0.0017	CcSEcCtD
Phenelzine—GPT2—Metabolism—RRM1—multiple sclerosis	0.000261	0.00418	CbGpPWpGaD
Phenelzine—Dyspepsia—Betamethasone—multiple sclerosis	0.00026	0.00167	CcSEcCtD
Phenelzine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00026	0.00167	CcSEcCtD
Phenelzine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000257	0.00165	CcSEcCtD
Phenelzine—Oedema—Prednisone—multiple sclerosis	0.000257	0.00165	CcSEcCtD
Phenelzine—GPT—Metabolism—GPC5—multiple sclerosis	0.000257	0.00411	CbGpPWpGaD
Phenelzine—Nausea—Mitoxantrone—multiple sclerosis	0.000256	0.00165	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000255	0.00164	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000255	0.00164	CcSEcCtD
Phenelzine—Fatigue—Betamethasone—multiple sclerosis	0.000254	0.00164	CcSEcCtD
Phenelzine—Fatigue—Dexamethasone—multiple sclerosis	0.000254	0.00164	CcSEcCtD
Phenelzine—Shock—Prednisone—multiple sclerosis	0.000253	0.00163	CcSEcCtD
Phenelzine—Tachycardia—Prednisone—multiple sclerosis	0.000251	0.00161	CcSEcCtD
Phenelzine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000249	0.004	CbGpPWpGaD
Phenelzine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000248	0.0016	CcSEcCtD
Phenelzine—Vision blurred—Methotrexate—multiple sclerosis	0.000248	0.0016	CcSEcCtD
Phenelzine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000244	0.00157	CcSEcCtD
Phenelzine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000243	0.00156	CcSEcCtD
Phenelzine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000243	0.00156	CcSEcCtD
Phenelzine—Malaise—Methotrexate—multiple sclerosis	0.000237	0.00153	CcSEcCtD
Phenelzine—MAOA—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000237	0.00379	CbGpPWpGaD
Phenelzine—Leukopenia—Methotrexate—multiple sclerosis	0.000235	0.00152	CcSEcCtD
Phenelzine—Dizziness—Prednisolone—multiple sclerosis	0.000234	0.0015	CcSEcCtD
Phenelzine—Asthenia—Triamcinolone—multiple sclerosis	0.000233	0.0015	CcSEcCtD
Phenelzine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000233	0.0015	CcSEcCtD
Phenelzine—Body temperature increased—Betamethasone—multiple sclerosis	0.000233	0.0015	CcSEcCtD
Phenelzine—Asthenia—Methylprednisolone—multiple sclerosis	0.000233	0.0015	CcSEcCtD
Phenelzine—Insomnia—Prednisone—multiple sclerosis	0.000232	0.0015	CcSEcCtD
Phenelzine—Paraesthesia—Prednisone—multiple sclerosis	0.000231	0.00148	CcSEcCtD
Phenelzine—Pruritus—Triamcinolone—multiple sclerosis	0.00023	0.00148	CcSEcCtD
Phenelzine—Pruritus—Methylprednisolone—multiple sclerosis	0.000229	0.00148	CcSEcCtD
Phenelzine—MAOB—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000229	0.00368	CbGpPWpGaD
Phenelzine—Convulsion—Methotrexate—multiple sclerosis	0.000228	0.00147	CcSEcCtD
Phenelzine—Dyspepsia—Prednisone—multiple sclerosis	0.000226	0.00146	CcSEcCtD
Phenelzine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000224	0.0036	CbGpPWpGaD
Phenelzine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000224	0.0036	CbGpPWpGaD
Phenelzine—Rash—Prednisolone—multiple sclerosis	0.000223	0.00143	CcSEcCtD
Phenelzine—Dermatitis—Prednisolone—multiple sclerosis	0.000223	0.00143	CcSEcCtD
Phenelzine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000221	0.00355	CbGpPWpGaD
Phenelzine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000221	0.00355	CbGpPWpGaD
Phenelzine—Fatigue—Prednisone—multiple sclerosis	0.000221	0.00143	CcSEcCtD
Phenelzine—Headache—Prednisolone—multiple sclerosis	0.000221	0.00143	CcSEcCtD
Phenelzine—Discomfort—Methotrexate—multiple sclerosis	0.000221	0.00142	CcSEcCtD
Phenelzine—Constipation—Prednisone—multiple sclerosis	0.00022	0.00141	CcSEcCtD
Phenelzine—Dizziness—Triamcinolone—multiple sclerosis	0.000215	0.00138	CcSEcCtD
Phenelzine—Dizziness—Methylprednisolone—multiple sclerosis	0.000214	0.00138	CcSEcCtD
Phenelzine—GPT—Metabolism—RRM1—multiple sclerosis	0.000213	0.00341	CbGpPWpGaD
Phenelzine—Feeling abnormal—Prednisone—multiple sclerosis	0.000212	0.00136	CcSEcCtD
Phenelzine—Asthenia—Betamethasone—multiple sclerosis	0.000212	0.00136	CcSEcCtD
Phenelzine—Asthenia—Dexamethasone—multiple sclerosis	0.000212	0.00136	CcSEcCtD
Phenelzine—Nausea—Prednisolone—multiple sclerosis	0.00021	0.00135	CcSEcCtD
Phenelzine—Pruritus—Betamethasone—multiple sclerosis	0.000209	0.00134	CcSEcCtD
Phenelzine—Pruritus—Dexamethasone—multiple sclerosis	0.000209	0.00134	CcSEcCtD
Phenelzine—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000208	0.00334	CbGpPWpGaD
Phenelzine—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000208	0.00334	CbGpPWpGaD
Phenelzine—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000208	0.00333	CbGpPWpGaD
Phenelzine—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000208	0.00333	CbGpPWpGaD
Phenelzine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000208	0.00134	CcSEcCtD
Phenelzine—Vomiting—Triamcinolone—multiple sclerosis	0.000207	0.00133	CcSEcCtD
Phenelzine—Vomiting—Methylprednisolone—multiple sclerosis	0.000206	0.00133	CcSEcCtD
Phenelzine—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000205	0.00329	CbGpPWpGaD
Phenelzine—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000205	0.00329	CbGpPWpGaD
Phenelzine—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000205	0.00329	CbGpPWpGaD
Phenelzine—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000205	0.00329	CbGpPWpGaD
Phenelzine—Rash—Triamcinolone—multiple sclerosis	0.000205	0.00132	CcSEcCtD
Phenelzine—Dermatitis—Triamcinolone—multiple sclerosis	0.000205	0.00132	CcSEcCtD
Phenelzine—Rash—Methylprednisolone—multiple sclerosis	0.000204	0.00132	CcSEcCtD
Phenelzine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000204	0.00131	CcSEcCtD
Phenelzine—Headache—Triamcinolone—multiple sclerosis	0.000204	0.00131	CcSEcCtD
Phenelzine—Headache—Methylprednisolone—multiple sclerosis	0.000203	0.00131	CcSEcCtD
Phenelzine—Body temperature increased—Prednisone—multiple sclerosis	0.000203	0.00131	CcSEcCtD
Phenelzine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000201	0.00323	CbGpPWpGaD
Phenelzine—Dizziness—Dexamethasone—multiple sclerosis	0.000195	0.00126	CcSEcCtD
Phenelzine—Dizziness—Betamethasone—multiple sclerosis	0.000195	0.00126	CcSEcCtD
Phenelzine—Insomnia—Methotrexate—multiple sclerosis	0.000194	0.00125	CcSEcCtD
Phenelzine—Nausea—Triamcinolone—multiple sclerosis	0.000193	0.00124	CcSEcCtD
Phenelzine—Paraesthesia—Methotrexate—multiple sclerosis	0.000193	0.00124	CcSEcCtD
Phenelzine—Nausea—Methylprednisolone—multiple sclerosis	0.000193	0.00124	CcSEcCtD
Phenelzine—Somnolence—Methotrexate—multiple sclerosis	0.000191	0.00123	CcSEcCtD
Phenelzine—Dyspepsia—Methotrexate—multiple sclerosis	0.000189	0.00122	CcSEcCtD
Phenelzine—Vomiting—Betamethasone—multiple sclerosis	0.000188	0.00121	CcSEcCtD
Phenelzine—Vomiting—Dexamethasone—multiple sclerosis	0.000188	0.00121	CcSEcCtD
Phenelzine—Rash—Betamethasone—multiple sclerosis	0.000186	0.0012	CcSEcCtD
Phenelzine—Rash—Dexamethasone—multiple sclerosis	0.000186	0.0012	CcSEcCtD
Phenelzine—Dermatitis—Dexamethasone—multiple sclerosis	0.000186	0.0012	CcSEcCtD
Phenelzine—Dermatitis—Betamethasone—multiple sclerosis	0.000186	0.0012	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000185	0.00119	CcSEcCtD
Phenelzine—Fatigue—Methotrexate—multiple sclerosis	0.000185	0.00119	CcSEcCtD
Phenelzine—Headache—Betamethasone—multiple sclerosis	0.000185	0.00119	CcSEcCtD
Phenelzine—Headache—Dexamethasone—multiple sclerosis	0.000185	0.00119	CcSEcCtD
Phenelzine—Asthenia—Prednisone—multiple sclerosis	0.000184	0.00119	CcSEcCtD
Phenelzine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000182	0.00292	CbGpPWpGaD
Phenelzine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000182	0.00292	CbGpPWpGaD
Phenelzine—Pruritus—Prednisone—multiple sclerosis	0.000182	0.00117	CcSEcCtD
Phenelzine—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.00018	0.00289	CbGpPWpGaD
Phenelzine—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.00018	0.00289	CbGpPWpGaD
Phenelzine—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000178	0.00285	CbGpPWpGaD
Phenelzine—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000178	0.00285	CbGpPWpGaD
Phenelzine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000177	0.00114	CcSEcCtD
Phenelzine—Nausea—Dexamethasone—multiple sclerosis	0.000175	0.00113	CcSEcCtD
Phenelzine—Nausea—Betamethasone—multiple sclerosis	0.000175	0.00113	CcSEcCtD
Phenelzine—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000175	0.0028	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—SRM—multiple sclerosis	0.000173	0.00278	CbGpPWpGaD
Phenelzine—Dizziness—Prednisone—multiple sclerosis	0.00017	0.00109	CcSEcCtD
Phenelzine—Body temperature increased—Methotrexate—multiple sclerosis	0.00017	0.00109	CcSEcCtD
Phenelzine—Vomiting—Prednisone—multiple sclerosis	0.000163	0.00105	CcSEcCtD
Phenelzine—Rash—Prednisone—multiple sclerosis	0.000162	0.00104	CcSEcCtD
Phenelzine—Dermatitis—Prednisone—multiple sclerosis	0.000162	0.00104	CcSEcCtD
Phenelzine—Headache—Prednisone—multiple sclerosis	0.000161	0.00104	CcSEcCtD
Phenelzine—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000161	0.00258	CbGpPWpGaD
Phenelzine—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000161	0.00258	CbGpPWpGaD
Phenelzine—CYP3A43—Biological oxidations—POMC—multiple sclerosis	0.000161	0.00258	CbGpPWpGaD
Phenelzine—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000158	0.00254	CbGpPWpGaD
Phenelzine—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000158	0.00254	CbGpPWpGaD
Phenelzine—Asthenia—Methotrexate—multiple sclerosis	0.000154	0.000991	CcSEcCtD
Phenelzine—Nausea—Prednisone—multiple sclerosis	0.000153	0.000982	CcSEcCtD
Phenelzine—Pruritus—Methotrexate—multiple sclerosis	0.000152	0.000977	CcSEcCtD
Phenelzine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00015	0.00241	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—BCHE—multiple sclerosis	0.00015	0.0024	CbGpPWpGaD
Phenelzine—MAOA—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000144	0.00231	CbGpPWpGaD
Phenelzine—Dizziness—Methotrexate—multiple sclerosis	0.000142	0.000914	CcSEcCtD
Phenelzine—Vomiting—Methotrexate—multiple sclerosis	0.000136	0.000878	CcSEcCtD
Phenelzine—Rash—Methotrexate—multiple sclerosis	0.000135	0.000871	CcSEcCtD
Phenelzine—Dermatitis—Methotrexate—multiple sclerosis	0.000135	0.00087	CcSEcCtD
Phenelzine—Headache—Methotrexate—multiple sclerosis	0.000134	0.000865	CcSEcCtD
Phenelzine—MAOB—Metabolism—SRM—multiple sclerosis	0.000131	0.00211	CbGpPWpGaD
Phenelzine—MAOA—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000131	0.0021	CbGpPWpGaD
Phenelzine—Nausea—Methotrexate—multiple sclerosis	0.000127	0.000821	CcSEcCtD
Phenelzine—MAOA—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000122	0.00196	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—CYP24A1—multiple sclerosis	0.000122	0.00196	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—CYP27B1—multiple sclerosis	0.000122	0.00196	CbGpPWpGaD
Phenelzine—GPT—Metabolism—BCHE—multiple sclerosis	0.000122	0.00196	CbGpPWpGaD
Phenelzine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000122	0.00195	CbGpPWpGaD
Phenelzine—MAOB—Biological oxidations—POMC—multiple sclerosis	0.000122	0.00195	CbGpPWpGaD
Phenelzine—ABAT—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000119	0.00191	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000117	0.00187	CbGpPWpGaD
Phenelzine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000116	0.00185	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—GPC5—multiple sclerosis	0.000112	0.00179	CbGpPWpGaD
Phenelzine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000109	0.00175	CbGpPWpGaD
Phenelzine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000109	0.00174	CbGpPWpGaD
Phenelzine—MAOA—Neuronal System—BCHE—multiple sclerosis	0.0001	0.00161	CbGpPWpGaD
Phenelzine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	9.66e-05	0.00155	CbGpPWpGaD
Phenelzine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	9.66e-05	0.00155	CbGpPWpGaD
Phenelzine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.53e-05	0.00153	CbGpPWpGaD
Phenelzine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.53e-05	0.00153	CbGpPWpGaD
Phenelzine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.4e-05	0.00151	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—RRM1—multiple sclerosis	9.25e-05	0.00148	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—CYP24A1—multiple sclerosis	9.25e-05	0.00148	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—CYP27B1—multiple sclerosis	9.25e-05	0.00148	CbGpPWpGaD
Phenelzine—ABAT—Neuronal System—MAPK1—multiple sclerosis	9.13e-05	0.00146	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—APOE—multiple sclerosis	9.01e-05	0.00145	CbGpPWpGaD
Phenelzine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.82e-05	0.00141	CbGpPWpGaD
Phenelzine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.8e-05	0.00141	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—GPC5—multiple sclerosis	8.46e-05	0.00136	CbGpPWpGaD
Phenelzine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.39e-05	0.00135	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—SRM—multiple sclerosis	8.24e-05	0.00132	CbGpPWpGaD
Phenelzine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	8.03e-05	0.00129	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—POMC—multiple sclerosis	7.74e-05	0.00124	CbGpPWpGaD
Phenelzine—MAOA—Biological oxidations—POMC—multiple sclerosis	7.64e-05	0.00122	CbGpPWpGaD
Phenelzine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.62e-05	0.00122	CbGpPWpGaD
Phenelzine—GPT—Metabolism—APOE—multiple sclerosis	7.34e-05	0.00118	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—ALB—multiple sclerosis	7.06e-05	0.00113	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—RRM1—multiple sclerosis	7.01e-05	0.00112	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—SRM—multiple sclerosis	6.98e-05	0.00112	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.91e-05	0.00111	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.91e-05	0.00111	CbGpPWpGaD
Phenelzine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.8e-05	0.00109	CbGpPWpGaD
Phenelzine—CYP3A7—Biological oxidations—POMC—multiple sclerosis	6.47e-05	0.00104	CbGpPWpGaD
Phenelzine—GPT—Metabolism—POMC—multiple sclerosis	6.31e-05	0.00101	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.17e-05	0.00099	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.17e-05	0.00099	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	6.13e-05	0.000983	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—CYP24A1—multiple sclerosis	5.81e-05	0.000931	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—CYP27B1—multiple sclerosis	5.81e-05	0.000931	CbGpPWpGaD
Phenelzine—GPT—Metabolism—ALB—multiple sclerosis	5.75e-05	0.000923	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—BCHE—multiple sclerosis	5.31e-05	0.000852	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—GPC5—multiple sclerosis	5.31e-05	0.000852	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—SRM—multiple sclerosis	5.06e-05	0.000811	CbGpPWpGaD
Phenelzine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.05e-05	0.00081	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—SRM—multiple sclerosis	5.04e-05	0.000809	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	4.92e-05	0.000789	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	4.92e-05	0.000789	CbGpPWpGaD
Phenelzine—CYP2E1—Biological oxidations—POMC—multiple sclerosis	4.68e-05	0.000752	CbGpPWpGaD
Phenelzine—CYP3A5—Biological oxidations—POMC—multiple sclerosis	4.68e-05	0.00075	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—GPC5—multiple sclerosis	4.5e-05	0.000721	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.45e-05	0.000713	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—RRM1—multiple sclerosis	4.4e-05	0.000706	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—SRM—multiple sclerosis	4.37e-05	0.000701	CbGpPWpGaD
Phenelzine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.09e-05	0.000656	CbGpPWpGaD
Phenelzine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	4.05e-05	0.00065	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—BCHE—multiple sclerosis	4.03e-05	0.000646	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—SRM—multiple sclerosis	3.9e-05	0.000626	CbGpPWpGaD
Phenelzine—MAOA—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.83e-05	0.000614	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—RRM1—multiple sclerosis	3.73e-05	0.000598	CbGpPWpGaD
Phenelzine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.61e-05	0.00058	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.59e-05	0.000576	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	3.56e-05	0.000571	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	3.56e-05	0.000571	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	3.55e-05	0.00057	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	3.55e-05	0.00057	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—GPC5—multiple sclerosis	3.26e-05	0.000523	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—GPC5—multiple sclerosis	3.25e-05	0.000521	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—APOE—multiple sclerosis	3.2e-05	0.000513	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.08e-05	0.000494	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.08e-05	0.000494	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.01e-05	0.000483	CbGpPWpGaD
Phenelzine—MAOA—Neuronal System—MAPK1—multiple sclerosis	2.93e-05	0.00047	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.82e-05	0.000452	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.75e-05	0.000441	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.75e-05	0.000441	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—POMC—multiple sclerosis	2.75e-05	0.000441	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—RRM1—multiple sclerosis	2.7e-05	0.000433	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.69e-05	0.000432	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.69e-05	0.000431	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—BCHE—multiple sclerosis	2.53e-05	0.000405	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.51e-05	0.000403	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—ALB—multiple sclerosis	2.5e-05	0.000402	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—APOE—multiple sclerosis	2.42e-05	0.000389	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—SRM—multiple sclerosis	2.35e-05	0.000376	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.33e-05	0.000374	CbGpPWpGaD
Phenelzine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.17e-05	0.000349	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—BCHE—multiple sclerosis	2.14e-05	0.000343	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.08e-05	0.000334	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—POMC—multiple sclerosis	2.08e-05	0.000334	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—ALB—multiple sclerosis	1.9e-05	0.000304	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.81e-05	0.00029	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.65e-05	0.000265	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.65e-05	0.000265	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.62e-05	0.000259	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.55e-05	0.000249	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.55e-05	0.000249	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.55e-05	0.000248	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—APOE—multiple sclerosis	1.52e-05	0.000244	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.51e-05	0.000242	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.42e-05	0.000227	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.39e-05	0.000223	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.34e-05	0.000215	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—POMC—multiple sclerosis	1.31e-05	0.000209	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—APOE—multiple sclerosis	1.29e-05	0.000207	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.27e-05	0.000203	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.25e-05	0.000201	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.2e-05	0.000192	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—ALB—multiple sclerosis	1.19e-05	0.000191	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—POMC—multiple sclerosis	1.11e-05	0.000177	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—ALB—multiple sclerosis	1.01e-05	0.000162	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—APOE—multiple sclerosis	9.33e-06	0.00015	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—APOE—multiple sclerosis	9.31e-06	0.000149	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—APOE—multiple sclerosis	8.06e-06	0.000129	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—POMC—multiple sclerosis	8.01e-06	0.000129	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—POMC—multiple sclerosis	8e-06	0.000128	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—ALB—multiple sclerosis	7.3e-06	0.000117	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—ALB—multiple sclerosis	7.29e-06	0.000117	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—APOE—multiple sclerosis	7.2e-06	0.000115	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.19e-06	0.000115	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—POMC—multiple sclerosis	6.93e-06	0.000111	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—ALB—multiple sclerosis	6.31e-06	0.000101	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—POMC—multiple sclerosis	6.18e-06	9.92e-05	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—ALB—multiple sclerosis	5.64e-06	9.04e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—APOE—multiple sclerosis	4.33e-06	6.94e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—POMC—multiple sclerosis	3.72e-06	5.96e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—ALB—multiple sclerosis	3.39e-06	5.44e-05	CbGpPWpGaD
